Patent · US Active

Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease

US10626180B2 · kind B2 · utility

12Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 19, 2018
Grant dateApr 21, 2020
Priority date
Expiry dateApr 19, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/56
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The aspects disclosed herein describe methods of identifying a subject that is non-responsive to anti-TNF therapy. The aspects disclosed herein further provide for a method of selecting a therapy for a subject with Inflammatory Bowel Disease (IBD), and treating the subject with the therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.